Elizabeth E Roughead1, Nicole Pratt, Andrew L Gilbert. 1. Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, University of South Australia, Adelaide, Australia. libby.roughead@unisa.edu.au
Abstract
AIM: To determine trends over 5 years in cardiovascular medicine use in the Australian veteran population with diabetes. METHODS: An observational study. All veterans dispensed medicines indicative of diabetes between 2000 and 2005 were identified from the Veterans Affairs pharmacy claims dataset. Concurrent dispensings of angiotensin-converting enzyme inhibitor (ACEI), lipid-lowering medicines and antiplatelets were assessed. RESULTS: ACEI/angiotensin II receptor blocker use has risen from 46% to 67% in the veteran population dispensed medicines indicative of diabetes. Lipid-lowering medicines have increased from 33% to 58% and antiplatelets from 28% to 50%. CONCLUSION: The increasing use of cardiovascular medicines in the diabetes population is suggestive of improved treatment practices over time, consistent with guidelines and quality use of medicines initiatives.
AIM: To determine trends over 5 years in cardiovascular medicine use in the Australian veteran population with diabetes. METHODS: An observational study. All veterans dispensed medicines indicative of diabetes between 2000 and 2005 were identified from the Veterans Affairs pharmacy claims dataset. Concurrent dispensings of angiotensin-converting enzyme inhibitor (ACEI), lipid-lowering medicines and antiplatelets were assessed. RESULTS: ACEI/angiotensin II receptor blocker use has risen from 46% to 67% in the veteran population dispensed medicines indicative of diabetes. Lipid-lowering medicines have increased from 33% to 58% and antiplatelets from 28% to 50%. CONCLUSION: The increasing use of cardiovascular medicines in the diabetes population is suggestive of improved treatment practices over time, consistent with guidelines and quality use of medicines initiatives.
Authors: Thomas M Kemp; Elizabeth L M Barr; Paul Z Zimmet; Adrian J Cameron; Timothy A Welborn; Stephen Colagiuri; Patrick Phillips; Jonathan E Shaw Journal: Diabetes Care Date: 2005-06 Impact factor: 19.112
Authors: Jennifer A Klinke; Jeffrey A Johnson; Lisa M Guirguis; Ellen L Toth; T K Lee; Richard Z Lewanczuk; Sumit R Majumdar Journal: Clin Ther Date: 2004-03 Impact factor: 3.393
Authors: Peter Gaede; Pernille Vedel; Nicolai Larsen; Gunnar V H Jensen; Hans-Henrik Parving; Oluf Pedersen Journal: N Engl J Med Date: 2003-01-30 Impact factor: 91.245
Authors: Alison L Supina; Lisa M Guirguis; Sumit R Majumdar; Richard Z Lewanczuk; T K Lee; Ellen L Toth; Jeffrey A Johnson Journal: Clin Ther Date: 2004-04 Impact factor: 3.393